Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing?
- PMID: 33007475
- PMCID: PMC7524530
- DOI: 10.1016/j.cmi.2020.09.033
Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing?
Comment on
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).Clin Microbiol Infect. 2021 Feb;27(2):244-252. doi: 10.1016/j.cmi.2020.08.010. Epub 2020 Aug 27. Clin Microbiol Infect. 2021. PMID: 32860964 Free PMC article.
References
-
- Sinha P., Matthay M.A., Calfee C.S. Is a "cytokine storm" relevant to COVID-19? JAMA Int Med. 2020 epub ahead of print. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
